Weight Loss
What Is Retatrutide? The Triple-Agonist Obesity Drug Explained
Retatrutide is an investigational once-weekly injectable being developed by Eli Lilly for obesity, and in clinical trials it has produced the largest weight loss…
Caring for Vaginal and Vulvar Health During Rapid Weight Loss
Rapid weight loss on a GLP-1 medication affects your whole body, including intimate tissue, so a little proactive care goes a long way toward…
Medicare GLP-1 Bridge vs Part D for Diabetes: Which Pays Less?
Here’s the short version before the details: these two routes almost never compete for the same person, so the real question isn’t which is…
TrumpRx and GLP-1s: What the Portal Does and Doesn’t Do
Picture someone hearing that a government website now sells Ozempic for a fraction of the old price, typing in their card, and expecting a…
Novo’s 2027 Price Cut to $675: Will You Actually Pay Less?
Here’s the headline and the asterisk in one breath. On January 1, 2027, Novo Nordisk will lower the list price of Wegovy, Ozempic, and…
NovoCare Pharmacy Explained: How Self-Pay Wegovy Works in 2026
NovoCare Pharmacy is Novo Nordisk’s own direct-to-patient pharmacy, and it’s the route to buy brand Wegovy at a self-pay cash price instead of the…
Foundayo (Orforglipron) Cost in 2026: What the Weight-Loss Pill Actually Costs
Foundayo, the brand name for Eli Lilly’s oral weight-loss drug orforglipron, costs $149 a month at the lowest dose and up to $349 a…
Diabetes Medications for Weight Loss That Actually Work
A diagnosis of type 2 diabetes usually comes with a list of new medications and a quiet hope that one of them might also…
Orforglipron Dosing Guide: The Titration Schedule and What to Expect
Orforglipron, sold as Foundayo, is a once-daily tablet you can take any time of day, with or without food or water. Dosing starts low…
